IDO1 and esophageal squamous cell carcinoma: However, multivariate Cox regression results showed that IDO had no significant correlation with the prognosis of ESCC patients, suggesting that serum HMGB1 was more valuable than IDO in predicting the prognosis of ESCC patients.